(VIANEWS) – Shares of Moderna (NASDAQ Composite: MRNA) fell by a staggering 26.08% in 30 days from $340.11 to $251.41 at 05:09 EST on Friday, following the last session’s upward trend. NASDAQ Composite is jumping 0.45% to $15,993.71, following the last session’s upward trend.
Moderna’s last close was $242.23, 51.31% under its 52-week high of $497.49.
Today’s last reported volume for Moderna is 7378346 which is 41.32% below its average volume of 12575966.
Moderna’s sales growth is 8216.6% for the current quarter and 1202.8% for the next. The company’s growth estimates for the ongoing quarter and the next is 1694.9% and 1681.2%, respectively.
Year-on-year quarterly revenue growth grew by 6398.5%, now sitting on 7.02B for the twelve trailing months.
Moderna’s Stock Yearly Top and Bottom Value
Moderna’s stock is valued at $251.41 at 05:09 EST, way below its 52-week high of $497.49 and way higher than its 52-week low of $83.83.
Moderna’s Moving Average
Moderna’s worth is way under its 50-day moving average of $334.78 and way below its 200-day moving average of $297.28.
More news about Moderna (MRNA).